Kimberly-Clark Completes $48.7 Billion Kenvue Acquisition
Kimberly-Clark has finalized its $48.7 billion acquisition of Kenvue, creating a global health and hygiene giant with ten billion-dollar brands including Neutrogena and Aveeno. The combined entity projects $31.6 billion in annual sales and significant cost synergies.

Kimberly-Clark has completed its $48.7 billion acquisition of Kenvue, merging their portfolios to create a single entity with ten billion-dollar brands. The deal, one of the largest of 2026, brings major beauty and health brands like Neutrogena, Aveeno, OGX, Listerine, and Tylenol under the Kimberly-Clark umbrella.
Mike Hsu, Chairman and CEO of Kimberly-Clark, marked the occasion. "Today marks a defining moment in Kimberly-Clark's 154-year history as we welcome Kenvue and hit the ground running as one company," he said. The combined company now serves more than 175 countries and claims its portfolio touches nearly half the world's population. Kenvue, which was spun off from Johnson & Johnson in May 2023, ceased trading on the New York Stock Exchange on November 2.
Financial Impact
The transaction is expected to deliver $2.1 billion in run-rate synergies within three years. This figure includes $1.9 billion in cost and expense reductions and $500 million in incremental profit from revenue growth, with $300 million earmarked for reinvestment. Kimberly-Clark expects its earnings per share to become accretive by the second year and intends to maintain a single-A credit rating, with leverage falling back to about 2.0 times.
| Segment | Annual Sales (Billions) |
|---|---|
| North America | $18.0 |
| Asia Pacific | $4.3 |
| EMEA | $5.0 |
| Enterprise Markets | $4.3 |
Brand and Market Reach
The merger creates a complementary portfolio anchored by ten brands each generating $1 billion or more in annual sales. Alongside Kimberly-Clark's personal-care staples like Kleenex, Huggies, and Kotex, the deal adds Kenvue's Neutrogena and Aveeno skincare lines, significantly expanding the new entity's footprint in the beauty market. The company will operate through four business segments covering North America, Asia-Pacific, EMEA, and enterprise markets including Latin America and India.
Operational Details
Kenvue shareholders received $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each share they held. The combined board of directors now comprises 13 members, with three Kenvue board members stepping down immediately after the transaction closed. Mike Hsu leads the board. The company claims it is well positioned to capture growing consumer demand for science-backed, high-performance solutions.
Kimberly-Clark, a Dividend King with 54 consecutive years of payout increases, saw its shares rise 0.3% to close at $108.25 on November 2. The acquisition's enterprise value was approximately $48.7 billion, including debt. With this move, Kimberly-Clark aims to become the number one company in the global health and hygiene products space.
Hsu expressed gratitude to the global teams. "I am deeply grateful to our Kimberly-Clark and Kenvue teams around the world for enabling this next step," he said.





